PROASSURANCE CORP
proassurance.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q1 FY2026 10-Q, filed May 5, 2026. Its latest SEC filing is a 15-12G/A from Jul 8, 2026.
10-Q for Q1 FY2026, filed May 5, 2026
The sections below describe the company as of the FY2025 annual report.
What Did They Do?
Sells medical professional liability insurance to healthcare providers and facilities, liability coverage for medical technology and life sciences companies, and workers’ compensation insurance.
10-K for FY2025, filed Feb 23, 2026Our Specialty P&C segment includes our MPL insurance operations, which represent the largest product line in our consolidated gross…View ↗
Our Specialty P&C segment focuses on medical professional liability insurance and medical technology liability insurance. Medical…View ↗
Workers' Compensation Insurance SegmentView ↗
How Did They Make Money?
-
10-K for FY2025, filed Feb 23, 2026
FY2025 revenue by reportable segment (Net investment income) ↗
$1.1B
-
10-K for FY2025, filed Feb 24, 2026
$1.1B ↗
| Segment | Share | Revenue |
|---|---|---|
|
Specialty P&C
|
0.0%
FY2022: 0.0%
|
Specialty P&C, FY2025
$0 Sources
|
|
Workers' Compensation Insurance
|
0.0%
FY2022: 0.0%
|
Workers' Compensation Insurance, FY2025
$0 Sources
|
|
Segregated Portfolio Cell Reinsurance
|
2.5%
FY2022: 1.1%
|
Segregated Portfolio Cell Reinsurance, FY2025
$3.9M Sources
|
|
Corporate
|
98%
FY2022: 99%
|
Corporate, FY2025
$152.6M Sources
|
Who Were Their Customers?
Healthcare providers and facilities buy medical professional liability coverage; medical technology and life sciences companies buy liability coverage. Independent agencies and brokers place much of the medical professional liability business and almost all medical technology coverage, while an internal business development team also writes medical professional liability policies.
10-K for FY2025, filed Feb 23, 2026Our Specialty P&C segment focuses on medical professional liability insurance and medical technology liability insurance. Medical…View ↗
Our MPL business is focused on providing professional liability insurance to healthcare providers and facilities. We target the full…View ↗
Underwriting analysis for MPL contemplates many factors including, but not limited to, the specific exposures, loss history, coverage…View ↗
December 31, 2025, approximately 62% of our MPL gross premiums written, excluding tail coverages, were produced through independent…View ↗
Underwriting analysis for Medical Technology Liability contemplates many factors including, but not limited to, the product's risk profile…View ↗
Did Revenues Turn Into Profits?
Yes. It kept 5 cents of every revenue dollar as net income in FY2025.
10-K for FY2025, filed Feb 24, 2026
$50.9MView ↗
How Were They Changing?
- Net income
-
Sources
10-Q for Q1 FY2026, filed May 6, 2026
$8.5MView ↗
- ▲ Now profitable
- vs −$5.8M in Q1 FY2025
10-Q for Q1 FY2026, filed May 5, 2026
Open tableView ↗
-
Jun 26, 2026
The Doctors Company completed its merger with ProAssurance
ProAssurance became a wholly owned subsidiary of The Doctors Company, and its common stock will no longer be listed on the NYSE.
Sources
8-K, filed Jun 26, 2026
On the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger (the “Effective Time”)…View ↗
Held flat. Revenue was $1.1B in FY2025, about the same as the $1.1B of FY2021.
Law firm liability coverage
The older report describes errors-and-omissions policies for law firms; the latest places that book in run-off and says renewal rights were sold to another party.
10-K for FY2022, filed Feb 27, 2023
Lloyd’s underwriting
The older report describes capital support for Lloyd’s underwriting; the latest says its Lloyd’s business is in run-off and that participation in underwriting results was discontinued.
10-K for FY2022, filed Feb 27, 2023 10-K for FY2025, filed Feb 23, 2026ProAssurance is a U.S. based specialty property and casualty and workers' compensation insurance carrier. Our specialty property and…View ↗
Our Lloyd's Syndicates business is currently in run-off, and our Specialty P&C segment includes the results from our participation in…View ↗
Loading...
